HGSI Related Hot List

Mar 9, 2011 05:23 PM Glaxo (GSK), Human Genome Sciences (HGSI) win FDA approval of lupus drug Benlysta

Nov 16, 2010 04:46 PM FDA panel recommends approval of benlysta in 13-2 vote (HGSI, GSK)

Aug 19, 2010 07:25 AM Human Genome (HGSI), Glaxo (GSK) report FDA priority review for Benlysta for Lupus; Says PDUFA date Dec. 9

Nov 2, 2009 06:51 AM Human Genome (HGSI) and GlaxoSmithKline Announced That BENLYSTA Met the Primary Endpoint in Second Phase 3 Trial

Jul 27, 2009 04:16 PM Human Genome Sciences (HGSI) to Offer 18M Shares

Jul 22, 2009 04:13 PM Human Genome Sciences (HGSI) Misses Street's Q2 Views

Jul 20, 2009 07:11 AM Human Genome Sciences (HGSI) Said BENLYSTA Met Primary Endpoint

Apr 29, 2009 04:11 PM Human Genome Sciences (HGSI) Tops Q1 Views

Jan 23, 2008 10:02 AM Human Genome (HGSI) Sinks After Changing Albuferon Dosing

Jun 6, 2006 06:44 AM Human Genome (HGSI) licensing agreement with Novartis for Albuferon

Jan 9, 2006 07:09 AM HGSI In License Deal with Amgen

Dec 13, 2005 04:11 PM HGSI To Spin-Off its CoGenesys division

Nov 17, 2005 07:22 AM HGSI Said Phase 2 Results of LymphoStat-B in Rheumatoid Arthritis Met Primary Endpoints

Oct 5, 2005 07:28 AM HGSI Said LymphoStat-B Drug Did Not Meet the Overall Primary Efficacy Endpoints

Jul 7, 2005 07:26 AM HGSI Says GSK Exercised Option to Develop and Commercialize LymphoStat-